Review Process

At Prostate Cancer Canada, we know that we have been entrusted with a very special mission – to allocate the funds raised by Canadians to programs that support research that will have the greatest potential to improve prostate cancer prevention, diagnosis and treatment and to better manage survivorship. To that end, we employ an equitable, transparent selection process that is free from bias to determine which proposals are funded.

We want to be strategic to ensure we are investing in the absolute best prostate cancer research conducted in this country that is also globally competitive.To do this, we engage leading experts in prostate cancer research to help develop the most effective research programs to allow our outstanding research community to achieve research success.

To ensure that Prostate Cancer Canada funds the best ideas, regardless of the area of specialization or where the research is conducted, each research proposal undergoes a rigorous peer-review process. In this way, high-quality, unbiased reviews by experts determine which research is funded.

Prostate Cancer Canada’s review process applies scientific rigor to decision-making related to research while ensuring the process is lean and efficient. Applicants receive feedback from the review process to help them to best assess their strengths and weaknesses to allow for continued improvement in future applications.  Furthermore,  PCC takes conflicts of interest between the review panel and applicants very seriously and has enacted measures to address such occurrences.

Review panels comprise prostate cancer researchers from across Canada who collectively represent all areas of the spectrum of prostate cancer research, including biomedical, translational and population health divisions. Additionally, representatives from the non-scientific, patient or survivor community are invited to serve on the review panel and fulfil a crucial role in giving the non-scientific community a voice at the table.

Subscribe to our free monthly e-newsletter!

* indicates required


PCC Spotlight
Hockey Fights Cancer Teams Up with Prostate Cancer Canada

Toronto – November 2nd, 2015 – Prostate Cancer Canada (PCC) is proud to be an official charitable partner in the 17th annual Hockey Fights Cancer™ (HFC) campaign.

Virus vs. Prostate Cancer: Canadian Researchers Pioneer Next-generation Therapy

Toronto –September 30, 2015 – A multi-disciplinary team of scientists and clinicians led by Dr.

Prostate Cancer Canada and the Movember Foundation partner to support research into better care and support for those living with the disease

September 1, 2015 – Toronto, ON – September is Prostate Cancer Awareness Month, an important time to reflect on the disease that affects one in eight Canadian men in their lifetime and kills 4,100, this year.

Prostate Cancer Canada Announces New Additions to its Board of Directors

TORONTO, ON - JULY 8th 2015 - Prostate Cancer Canada is pleased to announce the election of 5 new members to the PCC Board of Directors.

Prostate Cancer Canada Celebrates Wear Plaid for Dad Winner

JULY 8TH, 2015 - TORONTO, ON - Prostate Cancer Canada is thrilled to announce Borden Ladner Gervais (BLG) as the first-ever Wear Plaid for Dad National Workplace Champion.

Click here for news archive